TITLE

Role of residue 87 in substrate selectivity and regioselectivity of drug-metabolizing cytochrome P450 CYP102A1 M11

AUTHOR(S)
Vottero, Eduardo; Rea, Vanina; Lastdrager, Jeroen; Honing, Maarten; Vermeulen, Nico; Commandeur, Jan
PUB. DATE
August 2011
SOURCE
Journal of Biological Inorganic Chemistry;Aug2011, Vol. 16 Issue 6, p899
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
CYP102A1, originating from Bacillus megaterium, is a highly active enzyme which has attracted much attention because of its potential applicability as a biocatalyst for oxidative reactions. Previously we developed drug-metabolizing mutant CYP102A1 M11 by a combination of site-directed and random mutagenesis. CYP102A1 M11 contains eight mutations, when compared with wild-type CYP102A1, and is able to produce human-relevant metabolites of several pharmaceuticals. In this study, active-site residue 87 of drug-metabolizing mutant CYP102A1 M11 was mutated to all possible natural amino acids to investigate its role in substrate selectivity and regioselectivity. With alkoxyresorufins as substrates, large differences in substrate selectivities and coupling efficiencies were found, dependent on the nature of residue 87. For all combinations of alkoxyresorufins and mutants, extremely fast rates of NADPH oxidation were observed (up to 6,000 min). However, the coupling efficiencies were extremely low: even for the substrates showing the highest rates of O-dealkylation, coupling efficiencies were lower than 1%. With testosterone as the substrate, all mutants were able to produce three hydroxytestosterone metabolites, although with different activities and with remarkably different product ratios. The results show that the nature of the amino acid at position 87 has a strong effect on activity and regioselectivity in the drug-metabolizing mutant CYP102A1 M11. Because of the wide substrate selectivity of CYP102A1 M11 when compared with wild-type CYP102A1, this panel of mutants will be useful both as biocatalysts for metabolite production and as model proteins for mechanistic studies on the function of P450s in general.
ACCESSION #
62869107

 

Related Articles

  • Application of a new versatile electron transfer system for cytochrome P450-based Escherichia coli whole-cell bioconversions. Ringle, Michael; Khatri, Yogan; Zapp, Josef; Hannemann, Frank; Bernhardt, Rita // Applied Microbiology & Biotechnology;Sep2013, Vol. 97 Issue 17, p7741 

    Cytochromes P450 monooxygenases are highly interesting biocatalysts for biotechnological applications, since they perform a diversity of reactions on a broad range of organic molecules. Nevertheless, the application of cytochromes P450 is limited compared to other enzymes mainly because of the...

  • An overview on alcohol oxidases and their potential applications. Goswami, Pranab; Chinnadayyala, Soma; Chakraborty, Mitun; Kumar, Adepu; Kakoti, Ankana // Applied Microbiology & Biotechnology;May2013, Vol. 97 Issue 10, p4259 

    Alcohol oxidases (Alcohol: O Oxidoreductase; EC 1.1.3.x) are flavoenzymes that catalyze the oxidation of alcohols to the corresponding carbonyl compounds with a concomitant release of hydrogen peroxide. Based on substrate specificity, alcohol oxidases may be categorized broadly into four...

  • Dynamics and Hydration of the Active Sites of Mammalian Cytochromes P450 Probed by Molecular Dynamics Simulations. Hendrychová, Tereza; Berka, Karel; Navrátilová, Veronika; Anzenbacher, Pavel; Otyepka, Michal // Current Drug Metabolism;Feb2012, Vol. 13 Issue 2, p177 

    The flexibility, active site volume, solvation, and access path dynamics of six metabolically active mammalian cytochromes P450 (human 2A6, 2C9, 2D6, 2E1, 3A4 and rabbit 2B4) are extensively studied using molecular dynamics (MD) simulations. On average, the enzymes' overall structures...

  • The Role of Protein Plasticity in Computational Rationalization Studies on Regioselectivity in Testosterone Hydroxylation by Cytochrome P450 BM3 Mutants. De Beer, Stephanie B. A.; Van Bergen, Laura A. H.; Keijzer, Karlijn; Rea, Vanina; Venkataraman, Harini; Guerra, Célia Fonseca; Bickelhaupt, F. Matthias; Vermeulen, Nico P.E.; Commandeur, Jan N.M.; Geerke, Daan P. // Current Drug Metabolism;Feb2012, Vol. 13 Issue 2, p155 

    Recently, it was found that mutations in the binding cavity of drug-metabolizing Cytochrome P450 BM3 mutants can result in major changes in regioselectivity in testosterone (TES) hydroxylation. In the current work, we report the intrinsic reactivity of TES' C-H bonds and our attempts to...

  • Substrate binding to cytochromes P450. Isin, Emre M.; Guengerich, F. Peter // Analytical & Bioanalytical Chemistry;Nov2008, Vol. 392 Issue 6, p1019 

    P450s have attracted tremendous attention owing to not only their involvement in the metabolism of drug molecules and endogenous substrates but also the unusual nature of the reaction they catalyze, namely, the oxidation of unactivated C–H bonds. The binding of substrates to P450s, which...

  • Cytochrome P450 reductase from Candida apicola: versatile redox partner for bacterial P450s. Girhard, Marco; Tieves, Florian; Weber, Evelyne; Smit, Martha; Urlacher, Vlada // Applied Microbiology & Biotechnology;Feb2013, Vol. 97 Issue 4, p1625 

    Candida apicola belongs to a group of yeasts producing surface-active glycolipids consisting of sophorose and long-chain (ω)- or (ω-1)-hydroxy fatty acids. Hydroxylation of the fatty acids in this strain is likely catalyzed by cytochrome P450 monooxygenases (P450), which require reducing...

  • Identification of Selectivity Determinants in CYP Monooxygenases by Modelling and Systematic Analysis of Sequence and Structure. Seifert, Alexander; Pleiss, Jürgen // Current Drug Metabolism;Feb2012, Vol. 13 Issue 2, p197 

    Cytochrome P450 monooxygenases (CYPs) form a large, ubiquitous enzyme family and are of great interest in red and white biotechnology. To investigate the effect of protein structure on selectivity, the binding of substrate molecules near to the active site was modelled by molecular dynamics...

  • Malleability and Versatility of Cytochrome P450 Active Sites Studied by Molecular Simulations. Oostenbrink, Chris; De Ruiter, Anita; Hritz, Jozef; Vermeulen, Nico // Current Drug Metabolism;Feb2012, Vol. 13 Issue 2, p190 

    As the most important phase I drug metabolizing enzymes, the human Cytochromes P450 display an enormous versatility in the molecular structures of possible substrates. Individual isoforms may preferentially bind specific classes of molecules, but also within these classes, some isoforms show...

  • Structural and functional insights into polymorphic enzymes of cytochrome P450 2C8. Jiang, Hualin; Zhong, Fangfang; Sun, Lu; Feng, Weiyue; Huang, Zhong-Xian; Tan, Xiangshi // Amino Acids;Apr2011, Vol. 40 Issue 4, p1195 

    The cytochrome P450 (CYP) superfamily plays a key role in the oxidative metabolism of a wide range of drugs and exogenous chemicals. CYP2C8 is the principal enzyme responsible for the metabolism of the anti-cancer drug paclitaxel in the human liver. Nearly all previous works about polymorphic...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics